Private limited company · Asker
VETTRE APOTEK AS
ActiveRetail sale of pharmaceutical products (47.730)
The life line 2017–2026
Operating revenue per year, with recorded events above. As a table
Operating revenue 2025: NOK 18.6m.
Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.
In brief
VETTRE APOTEK AS is a private limited company in Asker, founded in 2017, in the industry retail sale of pharmaceutical products. The chief executive is Idar Bakke, and the chair of the board is Per Jørgen Søetorp Waaler. In 2025 the company had NOK 18.6m in operating revenue and a net profit of NOK 796k. The largest owner is PHARMCONSULT AS with 33.3%.
Put together by Intelligo from the sections below; each figure stands with its source where it belongs.
Overview
§ 01 Latest changes
4 changes, latest 18 Jul 2026
- Annual accounts filed 2024 → 2025
- Godkjente årsregnskap
- TAZ TRADING AS in as an owner with 33.3%
- Endring av daglig leder
Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →
Overview
§ 02 Worth knowing
1 point
- OKEquity ratio 34.3%, above the industry median
Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate
Overview
§ 03 Key figures
Revenue NOK 18.6m in 2025
Revenue
NOK 18.6m
+10.2% from 2024
20232025
Operating profit
NOK 782k
−26.0% from 2024
20232025
Net profit
NOK 796k
−20.0% from 2024
20232025
Equity
NOK 1.2m
+217.9% from 2024
20232025
Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →
Finances
§ 04 Where the money comes from and goes
Financial year 2025
Of every krone of operating revenue in 2025:
- Wages and social costs 12%
- Depreciation 0%
- Other operating costs 6%
- Not specified in the source 77%
- Left as operating result 4%
Source: the Register of Company Accounts via areg.no, read 15 Nov 2026
Finances
§ 05 Financial health
Equity ratio 34.3%
- VETTRE APOTEK AS, 2025
- Industry median, assumed: NOK 19.4m · 2.5% · 14.5% · +6.6%
Equity NOK 1.2m34% of the assets (NOK 3.4m)
Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 223 companies in 47.730 Retail sale of pharmaceutical products, not stated by the source.
Finances
§ 06 Accounts
9 years, latest 2025
| NOK 1,000 | 2023–25 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating revenue | 18,634 | 16,916 | 12,746 | |
| Operating profit | 782 | 1,057 | 336 | |
| Profit before tax | 796 | 996 | 249 | |
| Net profit | 796 | 996 | 249 | |
| Total assets | 3,388 | 2,776 | 3,808 | |
| Equity | 1,161 | 365 | −630 | |
| Liabilities | 2,226 | 2,411 | 4,438 |
Source: the Register of Company Accounts, read 15 Nov 2026 · All 9 years →
Management and ownership
§ 07 Officers
5 officers now
- REVISJONSSELSKAPET ASAuditor
- Per Jørgen Søetorp WaalerChair of the board
- Idar BakkeChief executive since 2023
- Ole Kristian ØydvinBoard member
- Ragnar SalmenBoard member
Source: the Brønnøysund Register Centre, read 22 Oct 2026 · All 5 roles, former ones too →
Management and ownership
§ 08 Signature, procuration and authorisations
Power of procuration:
Daglig leder eller styrets leder hver for seg.
The signature is word for word from the register. Source: the Register of Business Enterprises, read 2 Oct 2026
Management and ownership
§ 09 Owners
3 shareholders · largest 33.3%
| Owner | Share |
|---|---|
| PHARMCONSULT AS | 33.3% |
| PHARMORE AS | 33.3% |
| TAZ TRADING AS | 33.3% |
Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 3 owners →
Management and ownership
§ 10 Group
None registered
Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.
Management and ownership
§ 11 Portfolio
None registered
No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.
Management and ownership
§ 12 Network
21 connections
- Person
- Company
3 people link VETTRE APOTEK AS to 15 other companies: Ragnar Salmen 11, Ole Kristian Øydvin 2 and Per Jørgen Søetorp Waaler 2.
Source: the Brønnøysund Register Centre, read 22 Oct 2026 · Explore the network →
Events and registers
§ 13 Events
6 since 2017
Events per year
20172026
Since 2017: 4 announcements, 1 register change and 1 new and 0 former owners. Most happened in 2023 and 2024.
Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 16 Nov 2026. Register changes are Intelligo's own observations. · All 6 events →
Events and registers
§ 14 Notices
4, latest 16 Jul 2026
- Godkjente årsregnskap
- Godkjente årsregnskap
- Daglig leder
Source: The Brønnøysund Register Centre's announcements ↗, read 16 Nov 2026 · All 4 →
Events and registers
§ 15 Charges
Not fetched yet
Events and registers
§ 16 Other registers
Found in 3 of 7
- The Central Coordinating RegisterRegistered 13 Nov 2017
- VATRegistered
- The Register of Business EnterprisesRegistered 13 Nov 2017
- The Cleaning RegisterNot registered
- The Register of Staffing AgenciesNot registered
- Smiley scheme, the Norwegian Food Safety AuthorityNot registered
- The Financial Supervisory Authority's licence registerNot registered
Purpose: Apotekdrift, samt alt som hører naturlig til dette.
Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026
Market
§ 17 Tenders
None registered
No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.
Market
§ 18 Vacancies
None registered
No vacancies.No open ads at NAV. Checked 15 Nov 2026.
Market
§ 19 Competitors
Industry code 47.730
The companies most like it:
Compare themThe selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →
Last
§ 20 Questions and answers
6 questions
- Who is the chief executive of VETTRE APOTEK AS?
Idar Bakke, since 2023. § 07 - Who owns VETTRE APOTEK AS?
3 shareholders. The largest is PHARMCONSULT AS with 33.3%, PHARMORE AS with 33.3% and TAZ TRADING AS with 33.3%. § 09 - What was the revenue in 2025?
NOK 18.6m in the company. § 06 - Who is the auditor?
REVISJONSSELSKAPET AS. § 07 - Where is VETTRE APOTEK AS based?
Konglungveien 206, 1392 Vettre. - When was VETTRE APOTEK AS founded?
12 Oct 2017, registered in the Register of Business Enterprises 13 Nov 2017. § 16
The answers come from the sections linked to, with their sources.